Level Bio AB (publ)

DB:4MB Stock Report

Market Cap: €1.6m

Level Bio Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Joakim Granemo

Chief executive officer

SEK 1.0m

Total compensation

CEO salary percentage95.7%
CEO tenure1.3yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure4.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Joakim Granemo's remuneration changed compared to Level Bio's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-SEK 12m

Mar 31 2024n/an/a

-SEK 11m

Dec 31 2023SEK 1mSEK 981k

-SEK 9m

Sep 30 2023n/an/a

-SEK 5m

Jun 30 2023n/an/a

-SEK 4m

Mar 31 2023n/an/a

-SEK 4m

Dec 31 2022SEK 866kSEK 768k

-SEK 2m

Compensation vs Market: Joakim's total compensation ($USD93.24K) is below average for companies of similar size in the German market ($USD471.55K).

Compensation vs Earnings: Joakim's compensation has increased whilst the company is unprofitable.

CEO

Joakim Granemo (38 yo)

1.3yrs

Tenure

SEK 1,025,000

Compensation

Mr. Joakim Granemo is Chief Executive Officer of Level Bio AB (publ) from August 2023 and its Director from October 2022.

Board Members

NamePositionTenureCompensationOwnership
Joakim Granemo
CEO & Director2.1yrsSEK 1.03mno data
Ulrica Karlsson
CFO & Directorno dataSEK 928.00kno data
Helene Olsson
Director of Cybergene ABno dataSEK 605.00kno data
Mikael Havsjo
Director13.7yrsSEK 549.00kno data
Artur Aira
Chairman6.8yrsSEK 50.00kno data
Tobias Schön
Director1.8yrsSEK 50.00k5.1%
€ 84.1k
Neven Zoric
Director4.8yrsSEK 50.00kno data
Claes Gustafsson
Director of Techtum Lab ABno dataSEK 934.00kno data

4.8yrs

Average Tenure

55yo

Average Age

Experienced Board: 4MB's board of directors are considered experienced (4.8 years average tenure).